Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Mar 2026 for Biomarin Pharmaceutical INC, €207k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Alexander Hardy: trading record in brief
All filings by Alexander Hardy on record concern Biomarin Pharmaceutical Inc. We count 12 filings; the first trade dates from 1 December 2023 and the latest from 17 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 19 March 2026, reports a share grant of €207k in Biomarin Pharmaceutical Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alexander Hardy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
4,252 shares@ US$56.0515.2% of flowCommon StockSEC:0001628280-26-019847:0
2,941 shares@ US$58.5111.0% of flowCommon StockSEC:0001628280-26-019006:0
375 shares@ US$54.1371.3% of flowCommon StockSEC:0001628280-25-054856:0
16,570 shares@ US$55.0357.6% of flowCommon StockSEC:0001628280-25-054856:1
2,933 shares@ US$69.4413.8% of flowCommon StockSEC:0001048477-25-000027:0
300 shares@ US$56.0071.1% of flowCommon StockSEC:0001048477-24-000156:0
32,780 shares0Common StockSEC:0001048477-24-000040:0
68,039 shares0Common StockSEC:0001048477-23-000055:0
8 of 8 declarations
